D.W. Erkelens

2.8k total citations
59 papers, 2.2k citations indexed

About

D.W. Erkelens is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, D.W. Erkelens has authored 59 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 13 papers in Physiology. Recurrent topics in D.W. Erkelens's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (9 papers) and Cholesterol and Lipid Metabolism (8 papers). D.W. Erkelens is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (9 papers) and Cholesterol and Lipid Metabolism (8 papers). D.W. Erkelens collaborates with scholars based in Netherlands, Switzerland and Curacao. D.W. Erkelens's co-authors include Bert Bravenboer, A.C. Kappelle, Willem Hendrik Gispen, J.E.M. Groener, H Doorenbos, Geert Jan Biessels, J. B. L. Hoekstra, Tjerk W.A. de Bruin, W. D. Reitsma and Robin P. F. Dullaart and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

D.W. Erkelens

58 papers receiving 2.1k citations

Peers

D.W. Erkelens

EDM

SURGE

PHYSI

CCM

Anastasios Kalofoutis Greece

Edward J. Bastyr United States

Kazuo Takebe Japan

Felice D’Onofrio Italy

H N Ginsberg United States

Kari Kervinen Finland

Rex S. Clements United States

Muxun Zhang China

Alison Goldin United States

Masanori Iwase Japan

Anastasios Kalofoutis Greece

D.W. Erkelens

462 ×0.4

EDM

297 ×0.6

SURGE

365 ×0.7

PHYSI

459 ×1.2

376 ×1.2

CCM

Citations per year, relative to D.W. Erkelens D.W. Erkelens (= 1×) peers Anastasios Kalofoutis

Countries citing papers authored by D.W. Erkelens

Since Specialization

Citations

This map shows the geographic impact of D.W. Erkelens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.W. Erkelens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.W. Erkelens more than expected).

Fields of papers citing papers by D.W. Erkelens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.W. Erkelens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.W. Erkelens. The network helps show where D.W. Erkelens may publish in the future.

Co-authorship network of co-authors of D.W. Erkelens

This figure shows the co-authorship network connecting the top 25 collaborators of D.W. Erkelens. A scholar is included among the top collaborators of D.W. Erkelens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.W. Erkelens. D.W. Erkelens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erkelens, D.W. & P. Schwändt. (2002). Modern Aspects of Atherosclerosis and Treatment of Lipid Disorders. Atherosclerosis Supplements. 3(1). 1–2. 1 indexed citations

Stolk, Ronald P., et al.. (2002). Primary and secondary prevention in cardiovascular disease: an old‐fashioned concept?. Journal of Internal Medicine. 251(4). 301–306. 5 indexed citations

Cabezas, Manuel Castro, et al.. (2001). Gender differences in diurnal triglyceridemia in lean and overweight subjects. International Journal of Obesity. 25(12). 1767–1774. 50 indexed citations

Erkelens, D.W., et al.. (2000). Driving performance of hypoglycemia aware type 1 diabetic subjects during euglycemia and moderate hypoglycemia in a state-of-the-art moving-base driving simulator. Diabetologia. 43. 1 indexed citations

Smit, Johannes W. A., Tjerk W.A. de Bruin, Elisabeth M. W. Eekhoff, Jan F. C. Glatz, & D.W. Erkelens. (1999). Combined hyperlipidemia is associated with increased exercise-induced muscle protein release which is improved by triglyceride-lowering intervention. Metabolism. 48(12). 1518–1523. 3 indexed citations

Kanters, S. D. J. M., Ale Algra, Tjerk W.A. de Bruin, D.W. Erkelens, & J.D. Banga. (1999). Intensive lipid‐lowering strategy in patients with diabetes mellitus. Diabetic Medicine. 16(6). 500–508. 19 indexed citations

Beek, André P. van, et al.. (1997). Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans. Journal of Internal Medicine. 242(2). 125–129. 3 indexed citations

Cabezas, Manuel Castro, et al.. (1996). Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosis. European Journal of Clinical Investigation. 26(2). 89–108. 101 indexed citations

Smit, Johannes W. A., P.R. Bär, R. A. Geerdink, & D.W. Erkelens. (1995). Heterozygous familial hypercholesterolaemia is associated with pathological exercise‐induced leakage of muscle proteins, which is not aggravated by simvastatin therapy. European Journal of Clinical Investigation. 25(2). 79–84. 13 indexed citations

10.

Fijnheer, Rob, et al.. (1995). [Psychiatric drugs as risk factor in fatal heat stroke].. PubMed. 139(27). 1391–3. 5 indexed citations

11.

Tonstad, Serena, D Pometta, D.W. Erkelens, et al.. (1994). The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. European Journal of Clinical Pharmacology. 46(5). 405–410. 68 indexed citations

12.

Biessels, Geert Jan, A.C. Kappelle, Bert Bravenboer, D.W. Erkelens, & Willem Hendrik Gispen. (1994). Cerebral function in diabetes mellitus. Diabetologia. 37(7). 643–650. 287 indexed citations

13.

Bravenboer, Bert, et al.. (1994). Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4–9 analogue ORG 2766 in IDDM patients with neuropathy. Diabetologia. 37(4). 408–413. 10 indexed citations

14.

Bravenboer, Bert, et al.. (1993). ACTH4–9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats. Acta Diabetologica. 30(1). 21–24. 25 indexed citations

15.

Kappelle, A.C., et al.. (1993). Amelioration by the Ca²⁺antagonist, nimodipine of an existing neuropathy in the streptozotocin‐induced, diabetic rat. British Journal of Pharmacology. 108(3). 780–785. 24 indexed citations

16.

Gispen, W.H., A.C. Kappelle, Bert Bravenboer, J. Traber, & D.W. Erkelens. (1992). The Ca2+ antagonist nimodipine counteracts the onset of an experimental neuropathy in streptozotocin induced, diabetic rats. Neuroscience Research Communications. 10(2). 95–105. 17 indexed citations

17.

Bravenboer, Bert, et al.. (1992). Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia. 35(9). 813–817. 112 indexed citations

18.

Bravenboer, Bert, et al.. (1992). Thermal Threshold Testing for the Assessment of Small Fibre Dysfunction: Normal Values and Reproducibility. Diabetic Medicine. 9(6). 546–549. 44 indexed citations

19.

Koningsberger, J. C., et al.. (1991). No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma.. PubMed. 38(5-6). 199–203. 5 indexed citations

20.

Kortlandt, Wouter, et al.. (1989). A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus. Clinica Chimica Acta. 186(1). 109–117. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact